These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37975)

  • 1. Risk factors in calcium stone disease of the urinary tract.
    Robertson WG; Peacock M; Heyburn PJ; Marshall DH; Clark PB
    Br J Urol; 1978 Dec; 50(7):449-54. PubMed ID: 37975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A risk factor model of stone-formation.
    Robertson WG
    Front Biosci; 2003 Sep; 8():s1330-8. PubMed ID: 12957848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should recurrent calcium oxalate stone formers become vegetarians?
    Robertson WG; Peacock M; Heyburn PJ; Hanes FA; Rutherford A; Clementson E; Swaminathan R; Clark PB
    Br J Urol; 1979 Dec; 51(6):427-31. PubMed ID: 534817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some acid-base balance-dependent urinary parameters and calcium-binding anions in stone formers.
    Vogel E; Leskovar P; Schütz W
    Eur Urol; 1984; 10(4):254-9. PubMed ID: 6479200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies of urinary risk factors in urolithiasis].
    Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y; Minakata S; Yasukawa S; Fukatani T; Ohkawa T
    Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary risk factors in calcium oxalate stone disease: comparison of men and women.
    Ryall RL; Harnett RM; Hibberd CM; Mazzachi BC; Mazzachi RD; Marshall VR
    Br J Urol; 1987 Dec; 60(6):480-8. PubMed ID: 3427328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uric acid: an abettor or protector in calcium oxalate urolithiasis? Biochemical study in stone formers.
    Srinivasan S; Kalaiselvi P; Sakthivel R; Pragasam V; Muthu V; Varalakshmi P
    Clin Chim Acta; 2005 Mar; 353(1-2):45-51. PubMed ID: 15698589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidation of factors determining formation of calcium phosphate stones.
    Pak CY; Adams-Huet B
    J Urol; 2004 Dec; 172(6 Pt 1):2267-70. PubMed ID: 15538246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine stone risk factors in nephrolithiasis patients with and without bowel disease.
    Parks JH; Worcester EM; O'Connor RC; Coe FL
    Kidney Int; 2003 Jan; 63(1):255-65. PubMed ID: 12472791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evaluation of risk factors in male stone-formers attending a general hospital out-patient clinic.
    Ryall RL; Darroch JN; Marshall VR
    Br J Urol; 1984 Apr; 56(2):116-21. PubMed ID: 6498429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uric acid-binding proteins in calcium oxalate stone formers and their effect on calcium oxalate crystallization.
    Kalaiselvi P; Udayapriya KL; Selvam R
    BJU Int; 1999 Jun; 83(9):919-23. PubMed ID: 10368229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The most important metabolic risk factors in recurrent urinary stone formers.
    Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S
    Urol J; 2011; 8(2):99-106. PubMed ID: 21656467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical relationship between urine composition and urinary stone formation in stone forming patients.
    Abdel-Aziz AF; el-Waseef A; Abou el-Fotouh M
    Int Urol Nephrol; 1996; 28(4):457-64. PubMed ID: 9119628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of overweight and obesity in calcium oxalate stone formation.
    Siener R; Glatz S; Nicolay C; Hesse A
    Obes Res; 2004 Jan; 12(1):106-13. PubMed ID: 14742848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in urinary composition of calcium oxalate stone formers.
    Rahman B; Rahman MA
    Biomed Pharmacother; 1986; 40(3):108-10. PubMed ID: 3742009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The influence of uric acid on the calcium oxalate stone formation (author's transl)].
    Matouschek E; Huber R
    Urologe A; 1979 Jul; 18(4):211-4. PubMed ID: 38552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic stone composition in Egyptian children.
    Aggour A; Ziada AM; AbdelHamid AZ; AbdelRahman S; Morsi A
    J Pediatr Urol; 2009 Apr; 5(2):132-5. PubMed ID: 19059808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of the 24-hour urine analysis in the assessment of stone-formers attending a general hospital outpatient clinic.
    Ryall RL; Marshall VR
    Br J Urol; 1983 Feb; 55(1):1-5. PubMed ID: 6824849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic evaluation of patients with stone disease.
    Tiselius HG
    Urol Int; 1997; 59(3):131-41. PubMed ID: 9428428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.